# TRICIN: Prospective Study on the Efficacy of Single Topical Trichloroacetic Acid (TCA) 85% in the Treatment of Cervical Intraepithelial Neoplasia (CIN 1/2)

> **NCT04400578** · NA · COMPLETED · sponsor: **Krankenhaus Barmherzige Schwestern Linz** · enrollment: 102 (actual)

## Conditions studied

- Cervical Intraepithelial Neoplasia Grade 1
- Cervical Intraepithelial Neoplasia Grade 2

## Interventions

- **DEVICE:** Trichloroacetic acid 85% (TCA)

## Key facts

- **NCT ID:** NCT04400578
- **Lead sponsor:** Krankenhaus Barmherzige Schwestern Linz
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-07
- **Primary completion:** 2022-01-18
- **Final completion:** 2022-01-18
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2022-04-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04400578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04400578, "TRICIN: Prospective Study on the Efficacy of Single Topical Trichloroacetic Acid (TCA) 85% in the Treatment of Cervical Intraepithelial Neoplasia (CIN 1/2)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04400578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*